Evaluation of Intranasal Naltrexone and Naloxone

Clinical trial NCT03851731 · COMPLETED

Trial details

NCT number: NCT03851731
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid-use Disorder

Start date: 2015-10-05
Primary completion: 2015-11-07
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.